Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
A Pilot Study on the Drug Price Revision Strategy in Japan: A Comparison Among Fiscal Years 2018, 2020, and 2022.
Hosp Pharm
August 2024
Kaohsiung Medical University, Kaohsiung city, Taiwan.
Japan has resumed its health technology assessment to decide how to reduce high-cost drug prices. While drug price rules in Japan are comprehensive, they do not necessarily capture differences in product characteristics. This study examined the drug price revision strategy in Japan using migraine treatment with triptans as an example.
View Article and Find Full Text PDFComparative effects of drug interventions for the acute management of migraine episodes in adults: systematic review and network meta-analysis.
BMJ
September 2024
Department of Neurology, Danish Headache Centre, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Objective: To compare all licensed drug interventions as oral monotherapy for the acute treatment of migraine episodes in adults.
Design: Systematic review and network meta-analysis.
Data Sources: Cochrane Central Register of Controlled Trials, Medline, Embase, ClinicalTrials.
Comparison of New Pharmacologic Agents With Triptans for Treatment of Migraine: A Systematic Review and Meta-analysis.
JAMA Netw Open
October 2021
College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Article Synopsis
- New migraine treatments like lasmiditan and CGRP antagonists (rimegepant and ubrogepant) have been developed, providing alternatives to traditional triptans.
- A systematic review analyzed clinical trials comparing these new treatments against triptans for their effectiveness in managing acute migraine pain.
- Results indicated that while most treatments reduced pain at 2 hours, triptans generally showed better outcomes for both pain freedom and pain relief compared to lasmiditan, rimegepant, and ubrogepant.
[Comparison of triptans, NSAID and combination in migraine attack treatment].
Agri
July 2016
Department of Biostatistics, Çukurova University Faculty of Medicine, Adana, Turkey.
Objectives: Headache during migraine attack may recur during a single attack. The present study evaluated efficacy of both individual and combined use of agents from nonsteroidal anti-inflammatory drug (NSAID) and triptan groups widely used in treatment of migraine attacks.
Methods: A total of 201 attacks in 67 migraine patients were evaluated.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!